What's in Kelly's Bag?
What's in Kelly's Bag?
Kelly Ripa Stars in Public Service Announcements for “QVC Presents Super Saturday LIVE,” Benefitting Ovarian Cancer Research Fund WEST CHESTER, Pa. (June 10, 2014) – Kelly Ripa is shopping to … Continued
News
Press Release: Cancer Advocates Debunk Huckabee’s Misleadin...
Press Release: Cancer Advocates Debunk Huckabee’s Misleading Comments on Oral Contraceptives
Posted by adavis on January 24, 2014 FOR IMMEDIATE RELEASE: January 24, 2014 Washington, DC—In response to a recent speech by Mike Huckabee, in which he stated that women use oral contraceptives because … Continued
2014 ASCO Research Round-Up
2014 ASCO Research Round-Up
Posted by Laura Koontz on June 5, 2014 The 50th Annual Conference of the American Society of Clinical Oncology, held May 30 – June 3 in Chicago, featured a number of promising and thought … Continued
ASCO News: Two New Drugs Show Promise for Recurrent Ovarian...
ASCO News: Two New Drugs Show Promise for Recurrent Ovarian Cancer
(June 4, 2014) In a study presented at the American Society of Clinical Oncology annual meeting last week, researchers found that the combination of olaparib and cediranib (Recentin) kept recurrent … Continued
Partner Member Profile: Caring Together
Partner Member Profile: Caring Together
Partnership is a word you’ll hear often from the board members of Caring Together, a Partner Member of the Alliance in eastern New York. The support group was organized in … Continued
FDA Seeking Comments on Olaparib by June 11
FDA Seeking Comments on Olaparib by June 11
The Food and Drug Administration is seeking comments by June 11, 2014 on its review for Olaparib approval. Olaparib is an oral poly ADP-ribose polymerase (PARP) inhibitor that exploits DNA … Continued
Breastfeeding, Birth Control Pills May Reduce Ovarian Cance...
Breastfeeding, Birth Control Pills May Reduce Ovarian Cancer Risk Among Women with BRCA Gene Mutations
(May 16, 2014) Breastfeeding, tubal ligation – also known as having one’s “tubes tied” – and oral contraceptives may lower the risk of ovarian cancer for some women with BRCA … Continued
Few women offered genetic counseling services for breast an...
Few women offered genetic counseling services for breast and ovarian cancer risk
Despite recommendations from the federal government that women at high-risk of developing breast and ovarian cancer be offered genetic counseling and testing at no out of pocket cost, a new … Continued
OCRF Research Shows How Ovarian Tumors Elude Immune System
OCRF Research Shows How Ovarian Tumors Elude Immune System
(May 6, 2014) Tumors use numerous mechanisms to escape detection and killing by the immune system. Results from OCRF-funded research, reported May 4, 2014 in the prestigious journal Nature Medicine, … Continued
Alliance submits comments to FDA on off-label use of oncolo...
Alliance submits comments to FDA on off-label use of oncology drugs
This week, the Ovarian Cancer National Alliance submitted comments to the Food and Drug Administration (FDA) about a proposed Guidance for Industry that could have the effect of limiting patient … Continued
Imaging Predicts Response in Ovarian Cancer
Imaging Predicts Response in Ovarian Cancer
(April 30, 2014) A positive pretreatment imaging test more than doubled the likelihood of disease control in platinum-resistant advanced ovarian cancer treated with the folate receptor-targeted drug vintafolide (trade name … Continued
Partner Member Profile: Rhonda’s Club/Ovarian and Gyn...
Partner Member Profile: Rhonda’s Club/Ovarian and Gynecologic Cancer Coalition
Rhonda’s Club was founded in 1997, roughly the same time as the Ovarian Cancer National Alliance—and by some of the same people. Rhonda Oziel, Pat Goldman, Ann Kolker, Clare Donelan … Continued